Identifying  	Identifying  	 NNP	B-NP
Patient  	Patient  	 NNP	I-NP
Candidates  	Candidates  	 NNP	I-NP
for  	for  	 IN	I-NP
IL-1  	IL-1  	 NNP	I-NP
Inhibition 	Inhibition 	 NNP	I-NP
:  	:  	 :	O
Lessons  	Lessons  	 NNP	O
From  	From  	 IN	O
Real-World  	Real-World  	 JJ	B-NP
Cases  	Cases  	 NNS	I-NP
A  	A  	 DT	O
subgroup  	subgroup  	 NN	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
gouty  	gouty  	 JJ	O
arthritis  	arthritis  	 NNS	O
have  	have  	 VBP	O
a  	a  	 DT	O
chronic  	chronic  	 JJ	B-NP
recurring  	recurring  	 JJ	I-NP
form  	form  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
particularly  	particularly  	 RB	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
treat 	treat 	 VB	O
.  	.  	 .	O
Such  	Such  	 JJ	O
patients  	patients  	 NNS	O
experience  	experience  	 VBP	O
repeated  	repeated  	 VBN	O
flares  	flares  	 NNS	O
and  	and  	 CC	O
often  	often  	 RB	O
have  	have  	 VB	O
abundant  	abundant  	 JJ	O
tophi 	tophi 	 NN	B-NP
.  	.  	 .	O
Many  	Many  	 JJ	O
also  	also  	 RB	O
have  	have  	 VBP	O
underlying  	underlying  	 VBG	B-NP
comorbidities 	comorbidities 	 NN	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
renal  	renal  	 JJ	B-NP
impairment 	impairment 	 NN	I-NP
,  	,  	 ,	O
cardiovascular  	cardiovascular  	 JJ	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
gastrointestinal  	gastrointestinal  	 JJ	B-NP
disorders 	disorders 	 NNS	I-NP
,  	,  	 ,	O
obesity 	obesity 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
hypertension 	hypertension 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
contraindicate  	contraindicate  	 VBZ	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
standard  	standard  	 JJ	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
medications 	medications 	 NN	I-NP
.  	.  	 .	O
Five  	Five  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
treat  	treat  	 VB	O
gouty  	gouty  	 JJ	O
arthritis  	arthritis  	 NN	O
who  	who  	 WP	O
were  	were  	 VBD	O
either  	either  	 DT	O
candidates  	candidates  	 NNS	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
anti-IL  	anti-IL  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
are  	are  	 VBP	O
described 	described 	 VBN	O
.  	.  	 .	O
